Rating: SELL
SELL (5-tier) · mature cash generator · conviction: medium
| Metric | Value |
|---|---|
| Current Price | $443 |
| Triangulated Fair Value | $388 (-12% vs spot · triangulated FV) |
| 12-mo Scenario PWEV | $397 (-10% vs spot · 12m PWEV) |
| Forward P/E | 21.9x |
| Market Cap | $128B |
| 52-Week Range | $380–$574 |
EPS basis for the forward P/E and all scenario multiples: consensus forward EPS (broker-adjusted, non-GAAP).
Methodology: Valuation triangulated across five independent anchors — Monte Carlo (Student-t + regime switching), an independent DCF, peer re-rating, a sum-of-parts, and a scenario-weighted PWEV. Figures reconciled to Alpha Vantage 2026-06-27. Each chart below sits with the part of the thesis it evidences.
General research for a skeptical institutional reader. Not personalised investment advice; no position sizing or trade instructions. Figures as of the analysis date; verify before acting.
Investment Committee Summary
| Rating | SELL · SELL (5-tier) |
| Classification · conviction | mature cash generator · medium |
| Triangulated fair value | $388 (-12% vs spot · triangulated FV) |
| 12-mo scenario PWEV | $397 (-10% vs spot · 12m PWEV) |
| Next catalyst | 2026-07-30 — Quarterly earnings |
| Primary thesis-break | Ratings segment transaction revenue, year-on-year < -0.1 (2 consecutive prints) |
📎 Download the full model (Excel) — DCF line items, scenarios, sensitivity, assumptions, and extended fundamentals.
Rating Bridge
Rating = SELL because:
- Probability-weighted scenario value implies -10% vs spot
- Monte Carlo median implies -18% vs spot
- DCF fair value implies -13% vs spot
- Bear case (Structural — Volume / Subscription Decline / Competition) downside is -63% vs spot
- Net: reward/risk of 0.2× warrants a Sell.
Investment Thesis
At $407 on roughly $20 of forward adjusted EPS, the market is paying about 20x for a business it treats as a durable-compounder toll on capital markets — ratings, indices and recurring data with entrenched pricing power. That price already discounts mid-cycle issuance and steady subscription growth; it does not embed a re-rate. The engine largely agrees. Our base path holds the ~43.7% adjusted margin and 8% growth, and the probability-weighted target of $405 sits fractionally below spot, so the rating is HOLD, not a call to fade quality. The triangulation is tight: DCF fair value near $385, peer forward-P/E-implied around $416, all clustered close to the print. The variance decomposition shows 87% of the outcome dispersion comes from the P/E multiple — the debate is the rating, not the earnings. The single most damaging risk is a structural one: a credible data competitor or a durable issuance-recession that compresses the recurring base and the multiple at once, dragging the target toward the sub-$180 structural leg.
The dashboard below is the whole argument on one page: spot ($443) against each valuation anchor, the scenario tree, technicals and the options-implied move.
Anti-Thesis (The Real Bear Case)
The highest-probability bear leg is the base path simply not clearing its own hurdle. At 20x, SPGI is priced for uninterrupted mid-cycle issuance and mid-single-digit recurring growth, yet transaction ratings are cyclical and index fees are beta-linked. A soft issuance year plus one weak subscription print does not need a structural story to hurt: it caps EPS near $17–18, and a 20x multiple on lower earnings compresses the target well below spot before any de-rate. Because 87% of the modelled dispersion sits in the multiple, the market pays full price for durability it has not yet had to defend through a real downturn. The recession leg near $303 is the realistic disappointment, and it is more likely than the tail bull.
Key Debate
P/E Multiple explains 87% of Monte Carlo outcome variance — i.e. value is set by the multiple the market will pay, a rate/sentiment regime bet as much as an earnings bet.
Earnings-Call Disconfirmation & Sentiment
Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.
Management vs analyst tone (2026Q1): management +0.30 vs analyst floor +0.00 → delta +0.30 (n=23 mgmt / 16 Q&A; 33th pctile across the S&P book, z -0.6).
Flag: TYPICAL — management-vs-analyst tone within the normal cross-sectional range.
| Quarter | Mgmt | Analyst | Delta |
|---|---|---|---|
| 2026Q1 | +0.30 | +0.00 | +0.30 |
| 2025Q4 | +0.47 | +0.00 | +0.47 |
| 2025Q3 | +0.54 | +0.16 | +0.38 |
| 2025Q2 | +0.48 | +0.38 | +0.10 |
News (last 365d, 1000 articles): avg ticker sentiment +0.17 (bullish 13% / bearish 1%)
Scenario Analysis
The tree runs from a structural 'Structural — Volume / Subscription Decline / Competition' downside ($165) to a 'Bull — Re-Rate' bull case ($723); the probability-weighted blend (PWEV $397) is -10% versus spot.
| Scenario | Probability | Target | Return vs spot |
|---|---|---|---|
| Structural — Volume / Subscription Decline / Competition | 20% | $165 | -63% |
| Market-Activity Recession | 17% | $298 | -33% |
| Base — Recurring Data + Volume Growth | 35% | $406 | -8% |
| Growth — New Data / Index / Analytics | 20% | $566 | +28% |
| Bull — Re-Rate | 8% | $723 | +63% |
| Probability-Weighted (PWEV) | — | $397 | -10% |
Scenario rationale — what each probability buys (the driver path behind every target):
- Structural — Volume / Subscription Decline / Competition (20%, $165). Structural impairment — volume / subscription decline / competition: earnings AND the multiple compress together. Target sits below the 52-week low by construction. Drivers — implied_target: 178.2; probability: 0.2.
- Market-Activity Recession (17%, $298). Cyclical downturn — trading volumes + recurring data/index/ratings subscriptions + pricing power weakens for 1–2 years before normalising. Drivers — implied_target: 302.62; probability: 0.17.
- Base — Recurring Data + Volume Growth (35%, $406). Mid-cycle — normalised trading volumes + recurring data/index/ratings subscriptions + pricing power; disciplined capital allocation; steady returns. Drivers — implied_target: 420.3; probability: 0.35.
- Growth — New Data / Index / Analytics (20%, $566). Upside — new data / index / analytics lifts earnings above mid-cycle; the multiple expands modestly. Drivers — implied_target: 567.41; probability: 0.2.
- Bull — Re-Rate (8%, $723). Upside tail — sustained tight conditions or a structural re-rate on new data / index / analytics. Drivers — implied_target: 716.61; probability: 0.08.
Valuation Triangulation
Five anchors — but read them with their basis in mind. The Monte Carlo, the DCF terminal, and the peer re-rate all key off a market multiple, so they are not fully independent; only the discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat five numbers as five independent votes.
| Method | Basis | Fair Value | vs Spot |
|---|---|---|---|
| Monte Carlo median (Student-t + regime) | multiple | $365 | -18% |
| Peer P/E re-rate | multiple | $416 | -6% |
| Peer EV/Revenue re-rate | multiple | $426 | -4% |
| Scenario PWEV | multiple | $397 | -10% |
| DCF (5-year + terminal) | cash flow + terminal × | $384 | -13% |
| Triangulated (weighted) | — | $388 | -12% |
Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.
Monte Carlo — the distribution, not a point
10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $365 and 29% of paths finish above spot. The variance decomposition shows the p/e multiple is the dominant swing factor (87% of variance). Value is a multiple bet: fundamentals move the answer far less than the rating does.
DCF — the cash-flow anchor
Independent of the market multiple: a 5-year path, WACC 8.5%, 17x terminal FCF multiple → $384. This anchor is deliberately the heaviest (41%): it is the valuation least hostage to the current multiple regime.
Peer benchmarking — relative value
Against the peer cohort, re-rating to the peer-median forward multiple (P/E 20.53x) implies $416. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 12% so the market's mood does not drive the fair value.
Across all anchors the spread is 15% of the median — moderate (healthy method disagreement — read the blend with care).
Revenue-Segment Breakdown
The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)
| Segment | Revenue | Mix | Growth | Op margin | EBIT | Multiple | Capex % | Tag |
|---|---|---|---|---|---|---|---|---|
| Exchanges, Ratings & Market Data | $15.7B | 100% | 8% | 44% | $6.9B | 20x | 3% | ESTIMATE |
| EBIT = segment revenue × operating margin (segment EBITDA not shown — per-segment D&A is not separately disclosed). |
Named Exposures
Demand & pricing cycle (FACT/ESTIMATE)
| Dimension | Assessment |
|---|---|
| driver | trading volumes + recurring data/index/ratings subscriptions + pricing power |
| net_debt_or_cash_b | -12.09 |
Capital intensity & shareholder returns (ESTIMATE)
| Dimension | Assessment |
|---|---|
| capex_pct_revenue | 0.03 |
| div_yield | 0.0096 |
Structural risk vs optionality (INFERENCE)
| Dimension | Assessment |
|---|---|
| downside | volume / subscription decline / competition |
| upside | new data / index / analytics |
Industry Context — Financials — Exchanges
This name sits in the Financials — Exchanges as a exchange_data. trading volumes + recurring data/index/ratings subscriptions + pricing power Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.
Value chain: SPGI (exchange_data) · CME (exchange_data) · MCO (exchange_data) · ICE (exchange_data) · NDAQ (exchange_data) · MSCI (exchange_data) · COIN (exchange_data) · CBOE (exchange_data) · FDS (exchange_data)
| Shared state | Capex path | House view | This name implies |
|---|---|---|---|
| Volume / Subscription Decline / Competition | 37% | 37% | |
| Mid-Cycle — Recurring Data + Volume | 35% | 35% | |
| Upside — New Data / Index / Analytics | 28% | 28% |
Mapping note: name-level 'Structural — Volume / Subscription Decline / Competition' (20%) + 'Market-Activity Recession' (17%) map to cluster Volume / Subscription Decline / Competition (37%); name-level 'Growth — New Data / Index / Analytics' (20%) + 'Bull — Re-Rate' (8%) map to cluster Upside — New Data / Index / Analytics (28%) — the cluster row is the SUM of the mapped scenario probabilities, not a different estimate.
On the cluster's key downside — Volume / Subscription Decline / Competition () — this name implies 37% vs the cluster house view of 37% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.
Structure: Shared State — The fin_exchanges cycle is the shared macro driver. Driver — trading volumes + recurring data/index/ratings subscriptions + pricing power Dispersion — Members differ by cyclicality (quality compounders vs deep cyclicals).
Model Appendix
DCF — line items
| Year | Revenue | Op income | − Capex | + D&A | FCF | PV(FCF) |
|---|---|---|---|---|---|---|
| FY+1 | $17B | $8B | $0B | $0B | $6B | $6B |
| FY+2 | $18B | $9B | $0B | $0B | $7B | $6B |
| FY+3 | $20B | $10B | $0B | $0B | $7B | $6B |
| FY+4 | $21B | $10B | $0B | $0B | $8B | $6B |
| FY+5 | $22B | $11B | $0B | $0B | $8B | $6B |
| Terminal | — | — | — | — | $8B × 17x | $94B |
FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 3% of revenue, weighted from the segments) — not a single conversion fudge.
WACC 8.5% · Σ PV(FCF) $29B + PV(terminal) $94B = EV $123B; + net cash → equity $111B ÷ diluted shares 0.29B = $384/share (exit-multiple terminal).
- Gordon (perpetuity-growth) terminal at 2.5% → $386/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
- Incremental ROIC on the forecast capex ≈ 166% vs WACC 8% → above WACC — the build is value-creative.
Peer set
| Peer | EV/Rev | Fwd P/E | Growth | Op margin |
|---|---|---|---|---|
| CME | 12.16x | 18.38x | 8% | 70% |
| MCO | 10.47x | 26.6x | 8% | 46% |
| ICE | 6.69x | 18.05x | 8% | 57% |
| NDAQ | 6.41x | 22.68x | 8% | 48% |
| Median | 8.58x | 20.53x | — | — |
Peer-median fwd P/E → $416; EV/Rev → $426.
Weighted fair-value math
| Anchor | Value | Weight | Contribution |
|---|---|---|---|
| DCF | $384 | 41% | $158 |
| Scenario PWEV | $397 | 29% | $117 |
| Monte Carlo median | $365 | 18% | $64 |
| Peer P/E | $416 | 12% | $49 |
| Triangulated | — | 100% | $388 |
Sensitivity
DCF/share — WACC × terminal multiple
| WACC \ Term× | 11.9x | 14.4x | 17.0x | 19.5x | 22.1x |
|---|---|---|---|---|---|
| 6% | $314 | $367 | $422 | $475 | $530 |
| 8% | $300 | $350 | $403 | $453 | $505 |
| 8% | $286 | $334 | $384 | $433 | $483 |
| 10% | $273 | $319 | $367 | $413 | $461 |
| 10% | $261 | $305 | $351 | $395 | $440 |
DCF/share — revenue CAGR Δ × op-margin Δ
| CAGRΔ \ MgnΔ | -3.0pp | -1.5pp | +0.0pp | +1.5pp | +3.0pp |
|---|---|---|---|---|---|
| -3.0pp | $309 | $321 | $333 | $344 | $356 |
| -1.5pp | $333 | $345 | $358 | $370 | $383 |
| +0.0pp | $358 | $371 | $384 | $398 | $411 |
| +1.5pp | $384 | $398 | $412 | $427 | $441 |
| +3.0pp | $412 | $427 | $442 | $457 | $472 |
Tornado — DCF/share swing by driver (widest first)
| Driver | Low | High | Swing |
|---|---|---|---|
| Revenue CAGR ±3pp | $333 | $442 | $109 |
| Terminal × ±15% | $335 | $433 | $98 |
| Op margin ±3pp | $358 | $411 | $53 |
| WACC ±1pp | $367 | $403 | $36 |
| Capex intensity ±15% | $382 | $387 | $5 |
Company lever — SoP/share vs Exchanges, Ratings & Market Data multiple (AI re-rating) (base 20x)
| Multiple | 14.0x | 17.0x | 20.0x | 23.0x | 26.0x |
|---|---|---|---|---|---|
| SoP/share | $724 | $888 | $1,052 | $1,216 | $1,380 |
Consensus & Market Expectations
| Reference | Value |
|---|---|
| Street target (mean) | $463 (+4% vs spot · street) |
| House target | $405 (-12.5% vs street) |
| Sell-side coverage | 24 analysts (SB 5 / B 18 / H 1 / S 0 / SS 0; net score 0.58) |
_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.
Balance Sheet & Liquidity
| Metric | Value |
|---|---|
| Net debt | $12.4B — levered |
| Net debt / EBITDA | 1.57x |
| Interest coverage (EBIT / interest) | 22.7x |
| Current ratio | 0.82x |
| Lease obligations | $0.5B |
| Cash & ST investments | $1.8B |
Balance-sheet data as of 2025-12-31 (Alpha Vantage).
Capital Allocation
| Metric | Value |
|---|---|
| Free cash flow | $5.5B |
| Buybacks / dividends | $5.0B / $1.2B |
| Total shareholder yield | 4.8% |
| Payout as % of FCF | 113.1% |
| Reinvestment (capex / OCF) | 3.5% |
| SBC as % of FCF | 4.3% |
| Allocation stance | returning more than FCF (balance-sheet funded) |
Free-Cash-Flow Quality
| Metric | Value |
|---|---|
| FCF margin | 34.8% |
| FCF conversion (FCF / net income) | 113.2% |
| FCF yield | 4.3% |
| Capex intensity (capex / revenue) | 1.2% |
| FCF − SBC (diagnostic) | $5.2B |
| Capex split (maint / growth) | 60% / 40% — Capital-light data/analytics; growth slice is technology/cloud and data-platform build (Kensho, private-markets datasets), not physical assets. |
Accounting quality: SBC 1.5% of revenue; cash conversion (OCF/NI) 117% — cash-backed.
Catalyst Calendar
- 2026-07-30 (~22d) — Quarterly earnings — est. EPS $4.92 (AV EARNINGS_CALENDAR)
- 2026-10-01 (~85d) — Private-markets data / Kensho AI analytics product expansion (authored)
- 2026-11-12 (~127d) — Investor Day / medium-term margin and capital-return framework update (authored)
- 2027-01-28 (~204d) — Full-year adjusted EPS guidance for the next fiscal year (authored)
Forecast Track Record
- EPS surprise: beat 87.5% of the last 8 quarters; average surprise +5.5%.
Competitive Moat
Wide moat. Duopoly ratings (with Moody's), entrenched index franchises (S&P 500 licensing) and recurring data subscriptions give durable pricing power justifying a terminal multiple well above the market; the falsifiable claim is that if Market Intelligence organic subscription growth falls below ~4% for two years or a data competitor undercuts renewals, the moat is narrower than priced and the terminal multiple should compress toward the ~13x structural anchor rather than the ~20x base.
Moat sources:
- Ratings duopoly with Moody's and regulatory-embedded (NRSRO) mandates on rated debt
- S&P index franchise (S&P 500 and thousands of benchmarks) with asset-linked licensing lock-in
- High-switching-cost recurring data/analytics subscriptions (Market Intelligence, Kensho)
- Pricing power demonstrated through cycles across ratings and indices
Regulatory & Legal Risk
| Issue | Probability | Valuation sensitivity | Horizon |
|---|---|---|---|
| Credit-rating-agency oversight (SEC/ESMA) and conflict-of-interest rules | low (~20%) | low - incremental compliance cost, franchise intact; ~2-3% of FV | 12-24m |
| Index-licensing / benchmark-regulation and antitrust scrutiny of data pricing | low (~15%) | medium - pricing-power constraints would hit the highest-margin stream; ~5% of FV | 12-24m |
Probabilities and sensitivities are analyst estimates, not market-implied.
Scenario Macro & Key Risks
| Scenario | Macro assumption | Key risk |
|---|---|---|
| Structural — Volume / Subscription Decline / Competition | A durable issuance recession plus a credible data competitor undercutting renewals compresses the recurring base. | Index AUM re-prices lower and subscription share loss compresses margin and multiple together. |
| Market-Activity Recession | A cyclical issuance and trading trough as debt-issuance volumes fall in a risk-off year. | Transaction ratings fall sharply, denting EPS toward ~$17.5 even as subscriptions hold. |
| Base — Recurring Data + Volume Growth | Mid-cycle issuance with low-double-digit Market Intelligence and Indices growth and steady pricing. | At ~20x the base is fully priced; a single soft issuance year caps EPS and the multiple contracts on it. |
| Growth — New Data / Index / Analytics | Private-markets data, Kensho analytics and index AUM compound above trend with operating leverage. | New-data monetization fails to scale to the growth the premium multiple assumes. |
| Bull — Re-Rate | Sustained tight issuance and a durable analytics re-rate on entrenched pricing power. | A ~31x multiple is fragile given ~87% of variance sits in the multiple, not earnings. |
What the Market Is Pricing In
The house DCF sits 13% below spot, so the market is pricing in more than the house case — roughly 1.4pp of revenue CAGR.
Variant perception: the house view is below-consensus, and the thesis is primarily FCF-driven.
| Metric | Consensus | House | Importance |
|---|---|---|---|
| Revenue | — | 17.0 | High |
| EPS | — | 20.2 | Medium |
| Target price | 462.7 | 405.0 | Medium |
Peer Quality & Weighting
| Peer | Fwd P/E | Growth | Op margin | Quality | Weight cap |
|---|---|---|---|---|---|
| CME | 18.38× | 8% | 70% | direct | 100% |
| MCO | 26.6× | 8% | 46% | direct | 100% |
| ICE | 18.05× | 8% | 57% | direct | 100% |
| NDAQ | 22.68× | 8% | 48% | direct | 100% |
Quality-weighted forward P/E: 21.4× (simple median 20.53×). Direct peers count 100%, segment 50%, broad 25%.
Historical-range cross-check: 52-week range $380–$574, centre $467 (+5% vs spot); spot sits at the 33th percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.
Risk / Reward & Margin of Safety
| Metric | Value |
|---|---|
| Upside to triangulated FV | $388 (-12% vs spot · triangulated FV) |
| Downside to bear case (Structural — Volume / Subscription Decline / Competition) | $165 (-63% vs spot · bear scenario) |
| Reward/risk ratio | 0.2× |
| Margin of safety (FV vs spot) | -14% |
| P(price > spot) — Monte Carlo | 29% |
Reward/risk compares triangulated upside against the probability-weighted bear target, not the extreme tail. Bull case (Bull — Re-Rate): $723.
Assumption Register
| Assumption | Value | Used in | Source |
|---|---|---|---|
| WACC | 8.5% | DCF discount rate | estimate (CAPM) |
| Terminal multiple | 17× | DCF exit value | estimate (peer-anchored) |
| Terminal growth | 2.5% | DCF Gordon terminal | estimate |
| SBC dilution | 0.0%/yr | PWEV, MC, DCF (charged once) | estimate (from SBC/rev) |
| EPS basis | consensus forward EPS (broker-adjusted, non-GAAP) | all forward P/E & scenario multiples | definition |
Sensitivity-ranked drivers (widest fair-value swing first): Revenue CAGR ±3pp (109.0); Terminal × ±15% (98.0); Op margin ±3pp (53.0); WACC ±1pp (36.0); Capex intensity ±15% (5.0).
Inputs, Sources & Confidence
Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)
| Input | Value | Type | Source | Confidence | Used in |
|---|---|---|---|---|---|
| Revenue TTM | $15.7B | reported fact | 10-K/10-Q via AV | High | Forecast base, EV/Rev |
| FY+1 guided revenue | $17.0B | company guidance | Company guidance | Medium | Forecast, SoP |
| Diluted shares | 0.288B | reported fact | 10-K via AV | High | Market cap, per-share |
| Net debt / cash | $12.399B | reported fact | Balance sheet via AV | High | EV, DCF equity bridge |
| WACC | 8.5% | house estimate | CAPM (beta/rf) | Medium | DCF discount rate |
| Terminal multiple | 17× | house estimate | Peer/historical range | Medium | DCF exit value |
| Terminal growth | 2.5% | house estimate | Long-run GDP+ | Medium | DCF Gordon terminal |
Source Log
| Source | Type | Date | Used for | Reference |
|---|---|---|---|---|
| Alpha Vantage — GLOBAL_QUOTE / OVERVIEW | market data | 2026-07-08 | Price, market cap, EV, 52-week range, forward P/E | Alpha Vantage 2026-06-27 |
| Company income statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-07-08 | Revenue, gross/operating margin, EBIT, interest expense | INCOME_STATEMENT / latest annual |
| Company balance sheet (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-07-08 | Cash, debt, net debt, leases, equity, coverage | BALANCE_SHEET / latest annual |
| Company cash-flow statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-07-08 | Operating cash flow, capex, FCF, buybacks, dividends, SBC | CASH_FLOW / latest annual |
| Company earnings releases via Alpha Vantage | reported fact | 2026-07-08 | Reported EPS, surprise history | EARNINGS / quarterly |
| Earnings calendar via Alpha Vantage | market data | 2026-07-08 | Next earnings date, catalyst timing | EARNINGS_CALENDAR |
| Company guidance | company guidance | 2026-07-08 | FY guided revenue / non-GAAP EPS basis | company guidance / earnings call |
| MCH segment model (from filings & disclosures) | house estimate | 2026-07-08 | Segment revenue, margins, multiples, AI decomposition | company_context (authored, tagged) |
| MCH qualitative analysis | inference | 2026-07-08 | Moat, regulatory risk, scenario macro, catalysts | company_context enrichment (authored) |
| MCH investment thesis & falsification triggers | house estimate | 2026-07-08 | Thesis, anti-thesis, thesis-break signals | authored §5.3 |
Citation coverage: 13/14 mandated claims sourced. Filing URLs are not available via the market-data provider; company statements are cited as 10-K/10-Q via Alpha Vantage.
Load-Bearing Assumptions
DCF: WACC 8%, terminal multiple 17×, FY+5 revenue $22B. Triangulation leans 41% on DCF, 29% on PWEV.
Reasons the Thesis Could Fail (Falsifiable)
Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:
- Ratings segment transaction revenue, year-on-year < -0.1 (2 consecutive prints → Volume / Subscription Decline / Competition). Transaction ratings track debt issuance and are the most cyclical line; a sustained double-digit decline confirms the issuance-recession leg rather than a one-quarter air pocket.
- Market Intelligence organic subscription revenue growth, year-on-year < 0.04 (2 consecutive prints → Volume / Subscription Decline / Competition). The recurring subscription base is the structural pillar of the thesis; organic growth slipping below mid-single digits would signal share loss to a data competitor, not just cyclicality.
- Consolidated adjusted operating margin < 0.42 (2 consecutive prints → Mid-Cycle — Recurring Data + Volume). The base path assumes a ~43.7% margin; a drop through the midpoint between base and the recession leg would mark erosion of the pricing-power premium the multiple rests on.
- Indices asset-linked fee revenue, year-on-year < -0.05 (2 consecutive prints → Volume / Subscription Decline / Competition). Index AUM-linked fees are a beta-sensitive, high-margin stream; a sustained decline would combine a market drawdown with fee compression and directly hit the growth-scenario premium.
- Full-year adjusted diluted EPS guidance revision < 17.5 (single event → Mid-Cycle — Recurring Data + Volume). The base scenario implies roughly $20 of EPS; a guide cut toward the recession-scenario EPS level (~$17.5) would be a discrete signal the mid-cycle path is off-track.
Fact / Inference / Speculation
- FACT: Spot $443; 52-week range $380–$574; engine rating SELL; base-case target $405 (-9%). (source: Alpha Vantage 2026-06-27, 8 July 2026)
- INFERENCE: Triangulated FV $388 (-12% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the cash-flow anchor sits below the multiple-discipline core.
- SPECULATION: At current prices the embedded bet is that the market keeps paying the current multiple through the capex cycle — a regime call the engine cannot verify from fundamentals alone.
Recommendation: SELL
Defensive: rating SELL; triangulated fair value $388 (-12% vs spot) — the risk/reward is skewed to the downside on P/E Multiple. The debate is P/E Multiple — fundamentally a multiple/regime call.
Disclosures & Limitations
This report is for informational and research purposes only. It is not personalised investment advice and does not consider any investor's objectives, financial situation, risk tolerance, tax position, or liquidity needs.
- No suitability assessment has been performed for any individual.
- Market data may be delayed or inaccurate; figures are as of the analysis date.
- Model outputs (fair values, targets, scenario probabilities) are estimates and may be wrong.
- Forecasts are uncertain; past performance is not indicative of future returns.
- The author or publisher may hold positions in securities mentioned.
- Users should verify information against primary sources (company filings) before acting.
- Investing involves risk of loss; there is no guarantee any target price is achieved.
- Ratings follow a defined research methodology (12-month expected-return thresholds), not individual circumstances.